Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.53
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
9.52
-0.01 (-0.10%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Immatics Employees
Immatics had 678 employees as of March 31, 2026. The number of employees decreased by 33 or -4.64% since the number was last reported on December 31, 2025.
Employees
678
Change
-33
Growth
-4.64%
Revenue / Employee
$63,425
Profits / Employee
-$364,618
Market Cap
1.30B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Novavax | 749 |
| MannKind | 592 |
| EyePoint | 214 |
| MapLight Therapeutics | 133 |
| MoonLake Immunotherapeutics | 130 |
| Inhibrx Biosciences | 110 |
| Jade Biosciences | 55 |
IMTX News
- 26 days ago - Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting - GlobeNewsWire
- 27 days ago - Immatics announces presentation of extended data from Phase 1 trial of IMA401 - TheFly
- 27 days ago - Immatics announces updated Phase 1 data for its Prame TCR T-cell therapy - TheFly
- 27 days ago - Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer - GlobeNewsWire
- 4 weeks ago - Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting - GlobeNewsWire
- 6 weeks ago - Immatics reports Q1 EPS (43c), consensus (44c) - TheFly
- 6 weeks ago - Immatics Announces First Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 6 weeks ago - Immatics Earnings release: Q1 2026 - Filings